Repros Therapeutics (RPRX) Reports Q2 Loss of $0.18/Share

Repros Therapeutics (NASDAQ: RPRX) reported Q2 EPS of ($0.18), versus ($0.32) reported last year.

For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance